Amira F. Mahdi
Luimneach, M, Ireland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
3D in vitro blood-brain barrier models: recent advances and their role in brain disease research and therapy.
Journal: Frontiers in pharmacology
Published: June 06, 2025
Pre-Clinical Rationale for Amcenestrant Combinations in HER2+/ER+ Breast Cancer.
Journal: International journal of molecular sciences
Published: November 25, 2024
Neratinib plus dasatinib is highly synergistic in HER2-positive breast cancer in vitro and in vivo.
Journal: Translational oncology
Published: February 19, 2024
Collagen-I influences the post-translational regulation, binding partners and role of Annexin A2 in breast cancer progression.
Journal: Frontiers in oncology
Published: August 01, 2023
Evaluation of ABT-751, a novel anti-mitotic agent able to overcome multi-drug resistance, in melanoma cells.
Journal: Cancer chemotherapy and pharmacology
Published: July 28, 2023
Expression of Annexin A2 Promotes Cancer Progression in Estrogen Receptor Negative Breast Cancers.
Journal: Cells
Published: May 22, 2020
Collagen and fibronectin promote an aggressive cancer phenotype in breast cancer cells but drive autonomous gene expression patterns.
Journal: Gene
Published: April 29, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026